Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu

Cornelia Kamp, M.B.A.

Contact Information

Faculty Appointments

Biography

Professional Background

Ms. Kamp is a Senior Associate, Executive Director Strategic Initiatives, Clinical Materials Services Unit (CMSU) in the Center for Human Experimental Therapeutics (CHET). Ms. Kamp received her Masters in Business Administration from the William E. Simon School of Business Administration from the University of Rochester, with a dual major in Finance and Operations Management in 1994. Ms. Kamp has more than 20 years experience in pharmaceutical based research, both commercial and academic. Ms. Kamp established and leads the Clinical Materials Services Unit (CMSU) which provides packaging, labeling, distribution, return and destructions services for investigational drugs/devices. Ms. Kamp has served as the Senior Project Manager for numerous clinical studies in a number of neurological conditions. She was the Director of Operations for the Clinical Trials Coordination Center (CTCC), University of Rochester, for 8 years responsible for project and data management, monitoring and administration. She has also participated on the steering committees for a number of trials. Ms. Kamp was the Vice President of Operations, SCIREX Research Centers/Premier Research Group (PRG) a for-profit Contract Research Organization (CRO) for three years, overseeing four fully owned research sites, employing 140 clinic staff engaged in studies for acute pain. Additionally, she was responsible for establishing a fifth clinic with a fully functional OR during her tenure. Ms. Kamp has a primary research interest in: Clinical trial design; simplifying clinical materials (drugs/devices) procurement, packaging, labeling, and distribution; regulatory aspects of conducting international clinical trials; recruitment strategies; and site performance metrics.

Credentials

Education

1987
BS | St Univ at Binghamton
Biological Sciences/German Language & Literature

1994
MBA | University of Rochester
Finance & Operations Management

Publications

Journal Articles

6/8/2020
Smith SM, Dworkin RH, Turk DC, McDermott M, Eccleston C, Farrar JT, Rowbotham MC, Bhangwagar Z, Burke LB, Cowan P, Ellenberg SS, Evans SR, Freeman RL, Garrison LP, Iyengar S, Jadad A, Jensen MP, Junor R, Kamp C, Katz NP, Kesslak JP, Kopecky EA, Lissin D, Markman JD, Mease PJ, O'Connor AB, Patel KV, Raja SN, Sampaio C, Schoenfeld D, Singh J, Steigerwald I, Strand V, Tive LA, Tobias J, Wasan AD, Wilson HD. "Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations." Pain.. 2020 Jun 8; Epub 2020 Jun 08.

8/7/2019
Gan J, Wu Y, Gong X, Ma Y, Yu S, Gao J. "Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial." Trials.. 2019 Aug 7; 20(1):481. Epub 2019 Aug 07.

5/1/2019
de Moraes Silva MA, Flumignan RLG, Miranda F, Cardoso RS, Silva SGJ, Guedes HJ, Nakano LCU. "Protocol for a systematic review and meta-analysis of interventions for pathologic perforator veins in chronic venous disease." BMJ open.. 2019 May 1; 9(4):e024088. Epub 2019 May 01.

Books & Chapters

2010
Chapter Title: Study Conduct: Academic and Industry Perspectives
Book Title: Clinical Trials in Neurology: From Idea to Implementation
Author List: Ravina B, Cummings J, McDermott M, Poole M, Kamp C, Germain JM
Published By: Cambridge University Press 2010

2002
Chapter Title: Participant Recruitment and Retention in Clinical Trials
Book Title: Protecting Study Volunteers in Research: A Manual for Investigative Sites
Author List: Dunn C, Chadwick G, Kamp C, Shinaman A
Edited By: Sara Gambrill
Published By: Ken Getz 2002 in Boston

VIEW ALL PUBLICATIONS